Emerald Mutual Fund Advisers Trust Bluebird Bio, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 31, 2018	SELL	$99.64 - $127.59 $2.53 Million - $3.24 Million	-25,364 Closed	0 $0
Q1 2018 Apr 26, 2018	SELL	$105.8 - $150.94 $4.56 Million - $6.51 Million	-43,121 Reduced 62.96%	25,364 $4.33 Million
Q4 2017 Feb 06, 2018	SELL	$81.25 - $130.7 $6.45 Million - $10.4 Million	-79,412 Reduced 53.69%	68,485 $12.2 Million
Q3 2017 Oct 30, 2017	BUY	$57.74 - $91.42 $8.54 Million - $13.5 Million	147,897	147,897 $20.3 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.